Home›People›Anthony Zingale
AZ

Anthony Zingale

Director at Athos Therapeutics.

DirectorPublic company
Updated Nov 10, 2026·Latest SEC filing Sep 4, 2026·Suggest an edit

About Anthony Zingale

Anthony Zingale is a director at Athos Therapeutics.

Anthony Zingale reports to the SEC as a director or officer of 7 public companies, including Liveperson (LPSN), ON24 (ONTF) and Carbon Black (CBLK).

Anthony Zingale first appears on SEC filings in 2006.

Experience

This experience comes from Anthony Zingale's profile and from SEC filings. For roles taken from filings, the years are when the filings name Anthony Zingale in the role, so the role may have started earlier or lasted longer.

Athos Therapeutics, Inc. Current
Director
2023 – Present · Torrance, CA
Develops AI-assisted medicines for people with autoimmune and inflammatory diseases.
Harmonic Growth Partners Current
CEO Partner
2020 – Present
Liveperson Inc.
Director
2025 – 2026 · Public company (LPSN)
ON24 Inc.
Director
2022 – 2026 · Public company (ONTF)
Espressive
Board Member
2017 – 2025
ServiceMax
Chairman
2019 – 2023
Dynamic Signal
Board Member
2018 – 2021
Carbon Black, Inc.
Director
2015 – 2019 · Public company (CBLK)
Jive Software, Inc.
Chairman & CEO
Executive Chairman (2010 – 2017)
2010 – 2017 · Public company (JIVE)
Concentrix Servicesource Inc.
Director
2011 · Public company (SREV)
McAfee, Inc.
Director
2008 – 2011 · Public company (MFE)
Mercury Interactive Corp.
President & CEO, director
CEO & President (2004 – 2006)
2004 – 2006 · Public company (MERQ)
Clarify
CEO & President
1998 – 2001
Cadence Design Systems
SVP Worldwide Marketing
1988 – 1997
Daisy Systems
VP Marketing
1984 – 1987
Intel
Product Marketing
1980 – 1984

Key Colleagues at Startups

The people Anthony Zingale works with at each company, as listed on that company's latest Form D.

Athos Therapeutics, Inc. · Form D, May 15, 2026
CM
Carl McKinzie
Member of the Board
LS
Laurence Stein
Member of the Board
JC
Joel Cohen
Member of the Board
Dimitrios Iliopoulos
Dimitrios Iliopoulos
President & CEO, director
AP
Allan Pantuck
Chairman & CMO

Sources

  1. SECAthos Therapeutics, Inc. Form D, filed May 15, 2026
  2. SECForms 3, 4 and 5 filed by Anthony Zingale (SEC filer 1180246)